NovaSeq 6000Dx
Conduct in vitro diagnostics and clinical research on a single instrument
Receive your quote directly from the manufacturer.
Great results and quality data for clinical diagnosis
Molecular diagnostics and infectious disease and clinical diagnostics
Extremely user friendly instrument and accurate results for clinical diagnosis.
Review Date: 15 Nov 2023 | Illumina
The NovaSeq 6000Dx features dual modes for IVD and RUO applications, opening new possibilities across a range of sample types, sequencing methods, and clinical research applications.
Integrated data analysis with DRAGEN
The NovaSeq 6000Dx system includes a DRAGEN Server paired with the sequencer, enabling streamlined and accurate data analysis. The intuitive software interface makes it easy to maximize your analysis efficiency.
Intuitive, streamlined user interface
Plan and stagger your sequencing runs and analysis using Illumina Run Manager. Monitor run progress, control instrument, and user management from the instrument or remotely. Illumina Run Manager also helps ensure data security and privacy.
Flexible targeted sequencing
NovaSeq 6000Dx is compatible with Illumina DNA Prep with Enrichment Dx, a rapid library preparation and enrichment solution that works with fixed and custom panels for increased flexibility. Combined with the integrated DRAGEN for Illumina DNA Prep with Enrichment Dx App, the Novaseq 6000Dx enables a high-throughput clinical testing workflow.
Flexible for a variety of applications
From an integrated, unified interface, users can easily switch between RUO and IVD modes to run the NovaSeq 6000Dx instrument, offering the flexibility to perform IVD testing, translational development, and clinical research on a single platform.
Scientists’ Choice Awards: Innovative clinical diagnostics technologies recognized at ADLM 2023
The best new clinical diagnostics instruments and kits, chosen by healthcare professionals
Product Overview
Links
Featured products
Request Quote for All Products
TruSight Oncology Comprehensive
IlluminaThe first CE-marked IVD kitted solution for comprehensive genomic profiling (CGP) of DNA and RNA variants, plus MSI and TMB, for multiple solid tumor types.
MiSeqDx System
IlluminaThe MiSeqDx instrument is the first and only FDA-cleared in vitro diagnostic (IVD) next-generation sequencing (NGS) system. Designed specifically for the clinical laboratory environment, the MiSeqDx instrument offers a small, approximately 4 square feet (0.37 square meters) footprint, an easy-to-follow workflow, and data output tailored to the needs of clinical labs. In addition, the integrated software enables sample tracking, user traceability, and results interpretation.Taking advantage of proven Illumina sequencing by synthesis (SBS) chemistry, the MiSeqDx instrument provides accurate, reliable screening, and diagnostic testing.MiSeqDx System Features & Benefits: First and Only FDA-cleared IVD NGS System - As an FDA-cleared IVD system, the MiSeqDx instrument meets guaranteed performance characteristics so you can feel confident that you are generating accurate and reliable data. Simple NGS Workflow - The compact, all-in-one instrument incorporates cluster generation, paired-end fluidics, sequencing by synthesis chemistry, and complete data analysis. Enhanced User Security - Equipped with Illumina User Management Software that enables laboratories to control and trace system access, ensuring that only authorized personnel are running tests. Proven, Well-Published Technology - The most widely adopted NGS technology worldwide, with references in more than 3,300 peer-reviewed publications. The MiSeqDx system uses the same proven reversible-terminator SBS chemistry used by all Illumina sequencing platforms. User-Friendly, Intuitive Software - The first IVD NGS to offer a fully integrated sequencing ecosystem. Instrument software is accessed through a user-friendly touch screen interface. For In Vitro Diagnostic Use. Contact an Illumina representative for regional availability.
NextSeq™ 550Dx Next-Generation Sequencing System
IlluminaThe next level in diagnostic power for the clinical lab